<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-06-20" modified="2020-10-07" version="206">
<accession>Q13224</accession>
<accession>Q12919</accession>
<accession>Q13220</accession>
<accession>Q13225</accession>
<accession>Q14CU4</accession>
<accession>Q9UM56</accession>
<name>NMDE2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Glutamate receptor ionotropic, NMDA 2B</fullName>
<shortName>GluN2B</shortName>
</recommendedName>
<alternativeName>
<fullName>Glutamate [NMDA] receptor subunit epsilon-2</fullName>
</alternativeName>
<alternativeName>
<fullName>N-methyl D-aspartate receptor subtype 2B</fullName>
<shortName evidence="29">NMDAR2B</shortName>
<shortName>NR2B</shortName>
</alternativeName>
<alternativeName>
<fullName>N-methyl-D-aspartate receptor subunit 3</fullName>
<shortName>NR3</shortName>
<shortName evidence="30">hNR3</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">GRIN2B</name>
<name type="synonym">NMDAR2B</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Biochim. Biophys. Acta" volume="1260" first="105" last="108">
<title>Human N-methyl-D-aspartate receptor modulatory subunit hNR3: cloning and sequencing of the cDNA and primary structure of the protein.</title>
<authorList>
<person name="Adams S.L."/>
<person name="Foldes R.L."/>
<person name="Kamboj R.K."/>
</authorList>
<dbReference type="PubMed" id="7999784"/>
<dbReference type="DOI" id="10.1016/0167-4781(94)00189-a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT ASN-407</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="J. Pharmacol. Exp. Ther." volume="278" first="808" last="816">
<title>Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.</title>
<authorList>
<person name="Hess S.D."/>
<person name="Daggett L.P."/>
<person name="Crona J."/>
<person name="Deal C."/>
<person name="Lu C.-C."/>
<person name="Urrutia A."/>
<person name="Chavez-Noriega L."/>
<person name="Ellis S.B."/>
<person name="Johnson E.C."/>
<person name="Velicelebi G."/>
</authorList>
<dbReference type="PubMed" id="8768735"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="1997-02" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of GRIN2B human subunit.</title>
<authorList>
<person name="Mandich P."/>
<person name="Schito A.M."/>
<person name="Pizzuti A."/>
<person name="Ratti A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1994" name="Genomics" volume="22" first="216" last="218">
<title>Mapping of the human NMDAR2B receptor subunit gene (GRIN2B) to chromosome 12p12.</title>
<authorList>
<person name="Mandich P."/>
<person name="Schito A.M."/>
<person name="Bellone E."/>
<person name="Antonacci R."/>
<person name="Finelli P."/>
<person name="Rocchi M."/>
<person name="Ajmar F."/>
</authorList>
<dbReference type="PubMed" id="7959773"/>
<dbReference type="DOI" id="10.1006/geno.1994.1366"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-294 AND 661-1089</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="Neurosci. Lett." volume="239" first="49" last="53">
<title>mRNA distribution in adult human brain of GRIN2B, a N-methyl-D-aspartate (NMDA) receptor subunit.</title>
<authorList>
<person name="Schito A.M."/>
<person name="Pizzuti A."/>
<person name="Di Maria E."/>
<person name="Schenone A."/>
<person name="Ratti A."/>
<person name="Defferrari R."/>
<person name="Bellone E."/>
<person name="Mancardi G.L."/>
<person name="Ajmar F."/>
<person name="Mandich P."/>
</authorList>
<dbReference type="PubMed" id="9547169"/>
<dbReference type="DOI" id="10.1016/s0304-3940(97)00853-7"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="21477" last="21485">
<title>Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase.</title>
<authorList>
<person name="Wu Y."/>
<person name="Dowbenko D."/>
<person name="Spencer S."/>
<person name="Laura R."/>
<person name="Lee J."/>
<person name="Gu Q."/>
<person name="Lasky L.A."/>
</authorList>
<dbReference type="PubMed" id="10748157"/>
<dbReference type="DOI" id="10.1074/jbc.m909741199"/>
</citation>
<scope>INTERACTION WITH MAGI3</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2016" name="EMBO J." volume="35" first="1923" last="1934">
<title>Synaptonuclear messenger PRR7 inhibits c-Jun ubiquitination and regulates NMDA-mediated excitotoxicity.</title>
<authorList>
<person name="Kravchick D.O."/>
<person name="Karpova A."/>
<person name="Hrdinka M."/>
<person name="Lopez-Rojas J."/>
<person name="Iacobas S."/>
<person name="Carbonell A.U."/>
<person name="Iacobas D.A."/>
<person name="Kreutz M.R."/>
<person name="Jordan B.A."/>
</authorList>
<dbReference type="PubMed" id="27458189"/>
<dbReference type="DOI" id="10.15252/embj.201593070"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH GRIN1 AND PRR7</scope>
<scope>INTERACTION WITH PRR7</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2010" name="Nat. Genet." volume="42" first="1021" last="1026">
<title>Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.</title>
<authorList>
<person name="Endele S."/>
<person name="Rosenberger G."/>
<person name="Geider K."/>
<person name="Popp B."/>
<person name="Tamer C."/>
<person name="Stefanova I."/>
<person name="Milh M."/>
<person name="Kortum F."/>
<person name="Fritsch A."/>
<person name="Pientka F.K."/>
<person name="Hellenbroich Y."/>
<person name="Kalscheuer V.M."/>
<person name="Kohlhase J."/>
<person name="Moog U."/>
<person name="Rappold G."/>
<person name="Rauch A."/>
<person name="Ropers H.H."/>
<person name="von Spiczak S."/>
<person name="Tonnies H."/>
<person name="Villeneuve N."/>
<person name="Villard L."/>
<person name="Zabel B."/>
<person name="Zenker M."/>
<person name="Laube B."/>
<person name="Reis A."/>
<person name="Wieczorek D."/>
<person name="Van Maldergem L."/>
<person name="Kutsche K."/>
</authorList>
<dbReference type="PubMed" id="20890276"/>
<dbReference type="DOI" id="10.1038/ng.677"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATIONS</scope>
<scope>VARIANT MRD6 CYS-682</scope>
<scope>CHARACTERIZATION OF VARIANT MRD6 CYS-682</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2016" name="J. Med. Chem." volume="59" first="2760" last="2779">
<title>Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.</title>
<authorList>
<person name="Volgraf M."/>
<person name="Sellers B.D."/>
<person name="Jiang Y."/>
<person name="Wu G."/>
<person name="Ly C.Q."/>
<person name="Villemure E."/>
<person name="Pastor R.M."/>
<person name="Yuen P.W."/>
<person name="Lu A."/>
<person name="Luo X."/>
<person name="Liu M."/>
<person name="Zhang S."/>
<person name="Sun L."/>
<person name="Fu Y."/>
<person name="Lupardus P.J."/>
<person name="Wallweber H.J."/>
<person name="Liederer B.M."/>
<person name="Deshmukh G."/>
<person name="Plise E."/>
<person name="Tay S."/>
<person name="Reynen P."/>
<person name="Herrington J."/>
<person name="Gustafson A."/>
<person name="Liu Y."/>
<person name="Dirksen A."/>
<person name="Dietz M.G."/>
<person name="Liu Y."/>
<person name="Wang T.M."/>
<person name="Hanson J.E."/>
<person name="Hackos D."/>
<person name="Scearce-Levie K."/>
<person name="Schwarz J.B."/>
</authorList>
<dbReference type="PubMed" id="26919761"/>
<dbReference type="DOI" id="10.1021/acs.jmedchem.5b02010"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2016" name="Neuron" volume="89" first="983" last="999">
<title>Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.</title>
<authorList>
<person name="Hackos D.H."/>
<person name="Lupardus P.J."/>
<person name="Grand T."/>
<person name="Chen Y."/>
<person name="Wang T.M."/>
<person name="Reynen P."/>
<person name="Gustafson A."/>
<person name="Wallweber H.J."/>
<person name="Volgraf M."/>
<person name="Sellers B.D."/>
<person name="Schwarz J.B."/>
<person name="Paoletti P."/>
<person name="Sheng M."/>
<person name="Zhou Q."/>
<person name="Hanson J.E."/>
</authorList>
<dbReference type="PubMed" id="26875626"/>
<dbReference type="DOI" id="10.1016/j.neuron.2016.01.016"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2017" name="J. Neurosci." volume="37" first="2216" last="2233">
<title>Mutation Disrupts Dendritic Morphology and Synaptic Transmission, and Causes ASD-Related Behaviors.</title>
<authorList>
<person name="Stephenson J.R."/>
<person name="Wang X."/>
<person name="Perfitt T.L."/>
<person name="Parrish W.P."/>
<person name="Shonesy B.C."/>
<person name="Marks C.R."/>
<person name="Mortlock D.P."/>
<person name="Nakagawa T."/>
<person name="Sutcliffe J.S."/>
<person name="Colbran R.J."/>
</authorList>
<dbReference type="PubMed" id="28130356"/>
<dbReference type="DOI" id="10.1523/jneurosci.2068-16.2017"/>
</citation>
<scope>INTERACTION WITH CAMK2A</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2017" name="Mol. Pharmacol." volume="91" first="317" last="330">
<title>Functional evaluation of a de novo GRIN2A mutation identified in a patient with profound global developmental delay and refractory epilepsy.</title>
<authorList>
<person name="Chen W."/>
<person name="Tankovic A."/>
<person name="Burger P.B."/>
<person name="Kusumoto H."/>
<person name="Traynelis S.F."/>
<person name="Yuan H."/>
</authorList>
<dbReference type="PubMed" id="28126851"/>
<dbReference type="DOI" id="10.1124/mol.116.106781"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF MET-818</scope>
</reference>
<reference key="14" evidence="1 2 3">
<citation type="journal article" date="2016" name="Mol. Pharmacol." volume="89" first="541" last="551">
<title>A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.</title>
<authorList>
<person name="Stroebel D."/>
<person name="Buhl D.L."/>
<person name="Knafels J.D."/>
<person name="Chanda P.K."/>
<person name="Green M."/>
<person name="Sciabola S."/>
<person name="Mony L."/>
<person name="Paoletti P."/>
<person name="Pandit J."/>
</authorList>
<dbReference type="PubMed" id="26912815"/>
<dbReference type="DOI" id="10.1124/mol.115.103036"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.76 ANGSTROMS) OF 31-394 IN COMPLEX WITH GRIN1 AND SYNTHETIC INHIBITOR IFENPRODIL</scope>
<scope>SUBUNIT</scope>
<scope>GLYCOSYLATION AT ASN-74 AND ASN-341</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="Transl. Psychiatry" volume="1" first="E55" last="E55">
<title>Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.</title>
<authorList>
<consortium name="S2D team"/>
<person name="Tarabeux J."/>
<person name="Kebir O."/>
<person name="Gauthier J."/>
<person name="Hamdan F.F."/>
<person name="Xiong L."/>
<person name="Piton A."/>
<person name="Spiegelman D."/>
<person name="Henrion E."/>
<person name="Millet B."/>
<person name="Fathalli F."/>
<person name="Joober R."/>
<person name="Rapoport J.L."/>
<person name="DeLisi L.E."/>
<person name="Fombonne E."/>
<person name="Mottron L."/>
<person name="Forget-Dubois N."/>
<person name="Boivin M."/>
<person name="Michaud J.L."/>
<person name="Drapeau P."/>
<person name="Lafreniere R.G."/>
<person name="Rouleau G.A."/>
<person name="Krebs M.O."/>
</authorList>
<dbReference type="PubMed" id="22833210"/>
<dbReference type="DOI" id="10.1038/tp.2011.52"/>
</citation>
<scope>VARIANTS ILE-18; ASN-50; VAL-271; MET-362; VAL-825; ARG-1014; SER-1026; ARG-1342; LEU-1415; PHE-1424 AND PHE-1452</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2012" name="N. Engl. J. Med." volume="367" first="1921" last="1929">
<title>Diagnostic exome sequencing in persons with severe intellectual disability.</title>
<authorList>
<person name="de Ligt J."/>
<person name="Willemsen M.H."/>
<person name="van Bon B.W."/>
<person name="Kleefstra T."/>
<person name="Yntema H.G."/>
<person name="Kroes T."/>
<person name="Vulto-van Silfhout A.T."/>
<person name="Koolen D.A."/>
<person name="de Vries P."/>
<person name="Gilissen C."/>
<person name="del Rosario M."/>
<person name="Hoischen A."/>
<person name="Scheffer H."/>
<person name="de Vries B.B."/>
<person name="Brunner H.G."/>
<person name="Veltman J.A."/>
<person name="Vissers L.E."/>
</authorList>
<dbReference type="PubMed" id="23033978"/>
<dbReference type="DOI" id="10.1056/nejmoa1206524"/>
</citation>
<scope>VARIANT MRD6 LEU-553</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2012" name="Science" volume="338" first="1619" last="1622">
<title>Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.</title>
<authorList>
<person name="O'Roak B.J."/>
<person name="Vives L."/>
<person name="Fu W."/>
<person name="Egertson J.D."/>
<person name="Stanaway I.B."/>
<person name="Phelps I.G."/>
<person name="Carvill G."/>
<person name="Kumar A."/>
<person name="Lee C."/>
<person name="Ankenman K."/>
<person name="Munson J."/>
<person name="Hiatt J.B."/>
<person name="Turner E.H."/>
<person name="Levy R."/>
<person name="O'Day D.R."/>
<person name="Krumm N."/>
<person name="Coe B.P."/>
<person name="Martin B.K."/>
<person name="Borenstein E."/>
<person name="Nickerson D.A."/>
<person name="Mefford H.C."/>
<person name="Doherty D."/>
<person name="Akey J.M."/>
<person name="Bernier R."/>
<person name="Eichler E.E."/>
<person name="Shendure J."/>
</authorList>
<dbReference type="PubMed" id="23160955"/>
<dbReference type="DOI" id="10.1126/science.1227764"/>
</citation>
<scope>VARIANT MRD6 TYR-456</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2014" name="Ann. Neurol." volume="75" first="147" last="154">
<title>GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy.</title>
<authorList>
<person name="Lemke J.R."/>
<person name="Hendrickx R."/>
<person name="Geider K."/>
<person name="Laube B."/>
<person name="Schwake M."/>
<person name="Harvey R.J."/>
<person name="James V.M."/>
<person name="Pepler A."/>
<person name="Steiner I."/>
<person name="Hortnagel K."/>
<person name="Neidhardt J."/>
<person name="Ruf S."/>
<person name="Wolff M."/>
<person name="Bartholdi D."/>
<person name="Caraballo R."/>
<person name="Platzer K."/>
<person name="Suls A."/>
<person name="De Jonghe P."/>
<person name="Biskup S."/>
<person name="Weckhuysen S."/>
</authorList>
<dbReference type="PubMed" id="24272827"/>
<dbReference type="DOI" id="10.1002/ana.24073"/>
</citation>
<scope>INVOLVEMENT IN EIEE27</scope>
<scope>VARIANTS EIEE27 HIS-540; ILE-615 AND GLY-618</scope>
<scope>CHARACTERIZATION OF VARIANTS EIEE27 HIS-540; ILE-615 AND GLY-618</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2014" name="Mol. Genet. Metab." volume="113" first="161" last="170">
<title>Three rare diseases in one sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith-Magenis Syndrome, cytosolic PEPCK deficiency and NMDA receptor glutamate insensitivity.</title>
<authorList>
<person name="Adams D.R."/>
<person name="Yuan H."/>
<person name="Holyoak T."/>
<person name="Arajs K.H."/>
<person name="Hakimi P."/>
<person name="Markello T.C."/>
<person name="Wolfe L.A."/>
<person name="Vilboux T."/>
<person name="Burton B.K."/>
<person name="Fajardo K.F."/>
<person name="Grahame G."/>
<person name="Holloman C."/>
<person name="Sincan M."/>
<person name="Smith A.C."/>
<person name="Wells G.A."/>
<person name="Huang Y."/>
<person name="Vega H."/>
<person name="Snyder J.P."/>
<person name="Golas G.A."/>
<person name="Tifft C.J."/>
<person name="Boerkoel C.F."/>
<person name="Hanson R.W."/>
<person name="Traynelis S.F."/>
<person name="Kerr D.S."/>
<person name="Gahl W.A."/>
</authorList>
<dbReference type="PubMed" id="24863970"/>
<dbReference type="DOI" id="10.1016/j.ymgme.2014.04.001"/>
</citation>
<scope>VARIANT MRD6 GLY-413</scope>
<scope>CHARACTERIZATION OF VARIANT MRD6 GLY-413</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2014" name="PLoS Genet." volume="10" first="E1004772" last="E1004772">
<title>De novo mutations in moderate or severe intellectual disability.</title>
<authorList>
<person name="Hamdan F.F."/>
<person name="Srour M."/>
<person name="Capo-Chichi J.M."/>
<person name="Daoud H."/>
<person name="Nassif C."/>
<person name="Patry L."/>
<person name="Massicotte C."/>
<person name="Ambalavanan A."/>
<person name="Spiegelman D."/>
<person name="Diallo O."/>
<person name="Henrion E."/>
<person name="Dionne-Laporte A."/>
<person name="Fougerat A."/>
<person name="Pshezhetsky A.V."/>
<person name="Venkateswaran S."/>
<person name="Rouleau G.A."/>
<person name="Michaud J.L."/>
</authorList>
<dbReference type="PubMed" id="25356899"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1004772"/>
</citation>
<scope>VARIANT MRD6 GLU-820</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2016" name="Am. J. Hum. Genet." volume="99" first="1261" last="1280">
<title>Mechanistic insight into NMDA receptor dysregulation by rare variants in the GluN2A and GluN2B agonist binding domains.</title>
<authorList>
<person name="Swanger S.A."/>
<person name="Chen W."/>
<person name="Wells G."/>
<person name="Burger P.B."/>
<person name="Tankovic A."/>
<person name="Bhattacharya S."/>
<person name="Strong K.L."/>
<person name="Hu C."/>
<person name="Kusumoto H."/>
<person name="Zhang J."/>
<person name="Adams D.R."/>
<person name="Millichap J.J."/>
<person name="Petrovski S."/>
<person name="Traynelis S.F."/>
<person name="Yuan H."/>
</authorList>
<dbReference type="PubMed" id="27839871"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2016.10.002"/>
</citation>
<scope>VARIANTS MRD6 ARG-436; PHE-461 AND HIS-696</scope>
<scope>CHARACTERIZATION OF VARIANTS MRD6 GLY-413; ARG-436; TYR-456; PHE-461; CYS-682 AND HIS-696</scope>
<scope>CHARACTERIZATION OF VARIANT EIEE27 HIS-540</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="216" last="225">
<title>Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes.</title>
<authorList>
<consortium name="Clinical Study Group"/>
<person name="Parrini E."/>
<person name="Marini C."/>
<person name="Mei D."/>
<person name="Galuppi A."/>
<person name="Cellini E."/>
<person name="Pucatti D."/>
<person name="Chiti L."/>
<person name="Rutigliano D."/>
<person name="Bianchini C."/>
<person name="Virdo S."/>
<person name="De Vita D."/>
<person name="Bigoni S."/>
<person name="Barba C."/>
<person name="Mari F."/>
<person name="Montomoli M."/>
<person name="Pisano T."/>
<person name="Rosati A."/>
<person name="Guerrini R."/>
</authorList>
<dbReference type="PubMed" id="27864847"/>
<dbReference type="DOI" id="10.1002/humu.23149"/>
</citation>
<scope>VARIANT EIEE27 MET-15</scope>
<scope>VARIANT ALA-1439</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2017" name="PLoS Genet." volume="13" first="E1006536" last="E1006536">
<title>Molecular mechanism of disease-associated mutations in the pre-M1 helix of NMDA receptors and potential rescue pharmacology.</title>
<authorList>
<person name="Ogden K.K."/>
<person name="Chen W."/>
<person name="Swanger S.A."/>
<person name="McDaniel M.J."/>
<person name="Fan L.Z."/>
<person name="Hu C."/>
<person name="Tankovic A."/>
<person name="Kusumoto H."/>
<person name="Kosobucki G.J."/>
<person name="Schulien A.J."/>
<person name="Su Z."/>
<person name="Pecha J."/>
<person name="Bhattacharya S."/>
<person name="Petrovski S."/>
<person name="Cohen A.E."/>
<person name="Aizenman E."/>
<person name="Traynelis S.F."/>
<person name="Yuan H."/>
</authorList>
<dbReference type="PubMed" id="28095420"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1006536"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT MRD6 LEU-553</scope>
<scope>MUTAGENESIS OF PRO-553</scope>
</reference>
<comment type="function">
<text evidence="7 17 19 24 27">Component of NMDA receptor complexes that function as heterotetrameric, ligand-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Channel activation requires binding of the neurotransmitter glutamate to the epsilon subunit, glycine binding to the zeta subunit, plus membrane depolarization to eliminate channel inhibition by Mg(2+) (PubMed:8768735, PubMed:26919761, PubMed:26875626, PubMed:28126851). Sensitivity to glutamate and channel kinetics depend on the subunit composition (PubMed:8768735, PubMed:26875626). In concert with DAPK1 at extrasynaptic sites, acts as a central mediator for stroke damage. Its phosphorylation at Ser-1303 by DAPK1 enhances synaptic NMDA receptor channel activity inducing injurious Ca2+ influx through them, resulting in an irreversible neuronal death. Contributes to neural pattern formation in the developing brain. Plays a role in long-term depression (LTD) of hippocampus membrane currents and in synaptic plasticity (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="6 7 9 17 18 19 20 24 25 27">Heterotetramer. Forms heterotetrameric channels composed of two zeta subunits (GRIN1), and two epsilon subunits (GRIN2A, GRIN2B, GRIN2C or GRIN2D) (in vitro) (PubMed:8768735, PubMed:26919761, PubMed:26875626, PubMed:28126851, PubMed:26912815). Can also form heterotetrameric channels that contain at least one zeta subunit (GRIN1), at least one epsilon subunit, plus GRIN3A or GRIN3B (By similarity). In vivo, the subunit composition may depend on the expression levels of the different subunits (Probable). Found in a complex with GRIN1 and GRIN3B. Found in a complex with GRIN1, GRIN3A and PPP2CB. Interacts with PDZ domains of PATJ, DLG3 and DLG4. Interacts with HIP1 and NETO1 (By similarity). Interacts with MAGI3 (PubMed:10748157). Interacts with DAPK1 (By similarity). Found in a complex with GRIN1 and PRR7 (PubMed:27458189). Interacts with PRR7 (PubMed:27458189). Interacts with CAMK2A (PubMed:28130356). Interacts with ARC; preventing ARC oligomerization (By similarity). Interacts with TMEM25 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2256942">
<id>Q13224</id>
</interactant>
<interactant intactId="EBI-1383687">
<id>Q9UQM7</id>
<label>CAMK2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2256942">
<id>Q13224</id>
</interactant>
<interactant intactId="EBI-357481">
<id>Q12959</id>
<label>DLG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2256942">
<id>Q13224</id>
</interactant>
<interactant intactId="EBI-80389">
<id>P78352</id>
<label>DLG4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2256942">
<id>Q13224</id>
</interactant>
<interactant intactId="EBI-349596">
<id>Q62936</id>
<label>Dlg3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2256942">
<id>Q13224</id>
</interactant>
<interactant intactId="EBI-375655">
<id>P31016</id>
<label>Dlg4</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2256942">
<id>Q13224</id>
</interactant>
<interactant intactId="EBI-2008988">
<id>P62139</id>
<label>PPP1CA</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="17 19 24 27">Cell membrane</location>
<topology evidence="6">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="6">Cell junction</location>
<location evidence="6">Synapse</location>
<location evidence="6">Postsynaptic cell membrane</location>
<topology evidence="6">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="7">Late endosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="7">Lysosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="7">Cytoplasm</location>
<location evidence="7">Cytoskeleton</location>
</subcellularLocation>
<text evidence="7">Co-localizes with the motor protein KIF17 along microtubules.</text>
</comment>
<comment type="tissue specificity">
<text evidence="28">Primarily found in the fronto-parieto-temporal cortex and hippocampus pyramidal cells, lower expression in the basal ganglia.</text>
</comment>
<comment type="domain">
<text evidence="6">A hydrophobic region that gives rise to the prediction of a transmembrane span does not cross the membrane, but is part of a discontinuously helical region that dips into the membrane and is probably part of the pore and of the selectivity filter.</text>
</comment>
<comment type="PTM">
<text evidence="6 7">Phosphorylated on tyrosine residues (By similarity). Phosphorylation at Ser-1303 by DAPK1 enhances synaptic NMDA receptor channel activity (By similarity).</text>
</comment>
<comment type="disease" evidence="10 12 13 15 16 21 23">
<disease id="DI-03128">
<name>Mental retardation, autosomal dominant 6, with or without seizures</name>
<acronym>MRD6</acronym>
<description>A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD6 additional features may include seizures, hypotonia, abnormal movements, such as dystonia, and autistic features.</description>
<dbReference type="MIM" id="613970"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="14 21 22">
<disease id="DI-04289">
<name>Epileptic encephalopathy, early infantile, 27</name>
<acronym>EIEE27</acronym>
<description>A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent.</description>
<dbReference type="MIM" id="616139"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberrations involving GRIN2B has been found in patients with mental retardation. Translocations t(9;12)(p23;p13.1) and t(10;12)(q21.1;p13.1) with a common breakpoint in 12p13.1.</text>
</comment>
<comment type="similarity">
<text evidence="31">Belongs to the glutamate-gated ion channel (TC 1.A.10.1) family. NR2B/GRIN2B subfamily.</text>
</comment>
<dbReference type="EMBL" id="U90278">
<property type="protein sequence ID" value="AAB49993.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U88963">
<property type="protein sequence ID" value="AAD00659.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U11287">
<property type="protein sequence ID" value="AAB60368.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113618">
<property type="protein sequence ID" value="AAI13619.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113620">
<property type="protein sequence ID" value="AAI13621.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U28758">
<property type="protein sequence ID" value="AAA74930.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U28861">
<property type="protein sequence ID" value="AAA69919.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U28862">
<property type="protein sequence ID" value="AAA69920.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8662.1"/>
<dbReference type="PIR" id="I39066">
<property type="entry name" value="I39066"/>
</dbReference>
<dbReference type="PIR" id="S52086">
<property type="entry name" value="S52086"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000825.2">
<property type="nucleotide sequence ID" value="NM_000834.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011518930.1">
<property type="nucleotide sequence ID" value="XM_011520628.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011518931.1">
<property type="nucleotide sequence ID" value="XM_011520629.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016874708.1">
<property type="nucleotide sequence ID" value="XM_017019219.1"/>
</dbReference>
<dbReference type="PDB" id="1S11">
<property type="method" value="Model"/>
<property type="chains" value="A=403-543, B=660-801"/>
</dbReference>
<dbReference type="PDB" id="1S2S">
<property type="method" value="Model"/>
<property type="chains" value="A=405-543, B=660-801"/>
</dbReference>
<dbReference type="PDB" id="2IPV">
<property type="method" value="Model"/>
<property type="chains" value="X=404-768"/>
</dbReference>
<dbReference type="PDB" id="5EWJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.77"/>
<property type="chains" value="B/D=31-394"/>
</dbReference>
<dbReference type="PDB" id="5EWL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.98"/>
<property type="chains" value="B/D=31-394"/>
</dbReference>
<dbReference type="PDB" id="5EWM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.76"/>
<property type="chains" value="B/D=31-394"/>
</dbReference>
<dbReference type="PDBsum" id="1S11"/>
<dbReference type="PDBsum" id="1S2S"/>
<dbReference type="PDBsum" id="2IPV"/>
<dbReference type="PDBsum" id="5EWJ"/>
<dbReference type="PDBsum" id="5EWL"/>
<dbReference type="PDBsum" id="5EWM"/>
<dbReference type="SMR" id="Q13224"/>
<dbReference type="BioGRID" id="109161">
<property type="interactions" value="29"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-285">
<property type="entry name" value="NMDA receptor complex, GluN1-GluN2B"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-294">
<property type="entry name" value="NMDA receptor complex, GluN1-GluN2A-GluN2B"/>
</dbReference>
<dbReference type="DIP" id="DIP-41002N"/>
<dbReference type="IntAct" id="Q13224">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="MINT" id="Q13224"/>
<dbReference type="STRING" id="9606.ENSP00000477455"/>
<dbReference type="BindingDB" id="Q13224"/>
<dbReference type="ChEMBL" id="CHEMBL1904"/>
<dbReference type="DrugBank" id="DB00659">
<property type="generic name" value="Acamprosate"/>
</dbReference>
<dbReference type="DrugBank" id="DB06151">
<property type="generic name" value="Acetylcysteine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01238">
<property type="generic name" value="Aripiprazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00289">
<property type="generic name" value="Atomoxetine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00843">
<property type="generic name" value="Donepezil"/>
</dbReference>
<dbReference type="DrugBank" id="DB11823">
<property type="generic name" value="Esketamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB05956">
<property type="generic name" value="EVT-101"/>
</dbReference>
<dbReference type="DrugBank" id="DB00949">
<property type="generic name" value="Felbamate"/>
</dbReference>
<dbReference type="DrugBank" id="DB13146">
<property type="generic name" value="Fluciclovine (18F)"/>
</dbReference>
<dbReference type="DrugBank" id="DB06741">
<property type="generic name" value="Gavestinel"/>
</dbReference>
<dbReference type="DrugBank" id="DB00142">
<property type="generic name" value="Glutamic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00874">
<property type="generic name" value="Guaifenesin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00502">
<property type="generic name" value="Haloperidol"/>
</dbReference>
<dbReference type="DrugBank" id="DB08954">
<property type="generic name" value="Ifenprodil"/>
</dbReference>
<dbReference type="DrugBank" id="DB06738">
<property type="generic name" value="Ketobemidone"/>
</dbReference>
<dbReference type="DrugBank" id="DB06077">
<property type="generic name" value="Lumateperone"/>
</dbReference>
<dbReference type="DrugBank" id="DB09409">
<property type="generic name" value="Magnesium acetate tetrahydrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB09481">
<property type="generic name" value="Magnesium carbonate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01043">
<property type="generic name" value="Memantine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00454">
<property type="generic name" value="Meperidine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00333">
<property type="generic name" value="Methadone"/>
</dbReference>
<dbReference type="DrugBank" id="DB04896">
<property type="generic name" value="Milnacipran"/>
</dbReference>
<dbReference type="DrugBank" id="DB00312">
<property type="generic name" value="Pentobarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB01174">
<property type="generic name" value="Phenobarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB01708">
<property type="generic name" value="Prasterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00418">
<property type="generic name" value="Secobarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB01956">
<property type="generic name" value="Taurine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01520">
<property type="generic name" value="Tenocyclidine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00193">
<property type="generic name" value="Tramadol"/>
</dbReference>
<dbReference type="DrugCentral" id="Q13224"/>
<dbReference type="GlyGen" id="Q13224">
<property type="glycosylation" value="7 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q13224"/>
<dbReference type="PhosphoSitePlus" id="Q13224"/>
<dbReference type="BioMuta" id="GRIN2B"/>
<dbReference type="DMDM" id="14548162"/>
<dbReference type="jPOST" id="Q13224"/>
<dbReference type="MassIVE" id="Q13224"/>
<dbReference type="PaxDb" id="Q13224"/>
<dbReference type="PeptideAtlas" id="Q13224"/>
<dbReference type="PRIDE" id="Q13224"/>
<dbReference type="ProteomicsDB" id="59232"/>
<dbReference type="Antibodypedia" id="71655">
<property type="antibodies" value="1335 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000609686">
<property type="protein sequence ID" value="ENSP00000477455"/>
<property type="gene ID" value="ENSG00000273079"/>
</dbReference>
<dbReference type="GeneID" id="2904"/>
<dbReference type="KEGG" id="hsa:2904"/>
<dbReference type="UCSC" id="uc001rbt.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2904"/>
<dbReference type="DisGeNET" id="2904"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000273079.4"/>
<dbReference type="GeneCards" id="GRIN2B"/>
<dbReference type="GeneReviews" id="GRIN2B"/>
<dbReference type="HGNC" id="HGNC:4586">
<property type="gene designation" value="GRIN2B"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000273079">
<property type="expression patterns" value="Tissue enriched (brain)"/>
</dbReference>
<dbReference type="MalaCards" id="GRIN2B"/>
<dbReference type="MIM" id="138252">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="613970">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616139">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q13224"/>
<dbReference type="OpenTargets" id="ENSG00000273079"/>
<dbReference type="Orphanet" id="178469">
<property type="disease" value="Autosomal dominant non-syndromic intellectual disability"/>
</dbReference>
<dbReference type="Orphanet" id="3451">
<property type="disease" value="West syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28980"/>
<dbReference type="eggNOG" id="KOG1053">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155964"/>
<dbReference type="HOGENOM" id="CLU_002598_1_0_1"/>
<dbReference type="InParanoid" id="Q13224"/>
<dbReference type="KO" id="K05210"/>
<dbReference type="OMA" id="DKHGVVG"/>
<dbReference type="OrthoDB" id="188544at2759"/>
<dbReference type="PhylomeDB" id="Q13224"/>
<dbReference type="TreeFam" id="TF314731"/>
<dbReference type="PathwayCommons" id="Q13224"/>
<dbReference type="Reactome" id="R-HSA-3928662">
<property type="pathway name" value="EPHB-mediated forward signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-438066">
<property type="pathway name" value="Unblocking of NMDA receptors, glutamate binding and activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-442982">
<property type="pathway name" value="Ras activation upon Ca2+ influx through NMDA receptor"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6794361">
<property type="pathway name" value="Neurexins and neuroligins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849932">
<property type="pathway name" value="Synaptic adhesion-like molecules"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9022699">
<property type="pathway name" value="MECP2 regulates neuronal receptors and channels"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9032500">
<property type="pathway name" value="Activated NTRK2 signals through FYN"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9609736">
<property type="pathway name" value="Assembly and cell surface presentation of NMDA receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9617324">
<property type="pathway name" value="Negative regulation of NMDA receptor-mediated neuronal transmission"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9620244">
<property type="pathway name" value="Long-term potentiation"/>
</dbReference>
<dbReference type="SignaLink" id="Q13224"/>
<dbReference type="SIGNOR" id="Q13224"/>
<dbReference type="BioGRID-ORCS" id="2904">
<property type="hits" value="3 hits in 870 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="GRIN2B">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="GRIN2B"/>
<dbReference type="GenomeRNAi" id="2904"/>
<dbReference type="Pharos" id="Q13224">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:Q13224"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="RNAct" id="Q13224">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000273079">
<property type="expression patterns" value="Expressed in buccal mucosa cell and 76 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q13224">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q13224">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005856">
<property type="term" value="C:cytoskeleton"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005770">
<property type="term" value="C:late endosome"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005764">
<property type="term" value="C:lysosome"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0017146">
<property type="term" value="C:NMDA selective glutamate receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014069">
<property type="term" value="C:postsynaptic density"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098839">
<property type="term" value="C:postsynaptic density membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045211">
<property type="term" value="C:postsynaptic membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097060">
<property type="term" value="C:synaptic membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001540">
<property type="term" value="F:amyloid-beta binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016595">
<property type="term" value="F:glutamate binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0022849">
<property type="term" value="F:glutamate-gated calcium ion channel activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016594">
<property type="term" value="F:glycine binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015276">
<property type="term" value="F:ligand-gated ion channel activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004972">
<property type="term" value="F:NMDA glutamate receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097553">
<property type="term" value="P:calcium ion transmembrane import into cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007268">
<property type="term" value="P:chemical synaptic transmission"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0048013">
<property type="term" value="P:ephrin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0098976">
<property type="term" value="P:excitatory chemical synaptic transmission"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060079">
<property type="term" value="P:excitatory postsynaptic potential"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007215">
<property type="term" value="P:glutamate receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007611">
<property type="term" value="P:learning or memory"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060291">
<property type="term" value="P:long-term synaptic potentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007275">
<property type="term" value="P:multicellular organism development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902951">
<property type="term" value="P:negative regulation of dendritic spine maintenance"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2001056">
<property type="term" value="P:positive regulation of cysteine-type endopeptidase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901216">
<property type="term" value="P:positive regulation of neuron death"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051290">
<property type="term" value="P:protein heterotetramerization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000310">
<property type="term" value="P:regulation of NMDA receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048167">
<property type="term" value="P:regulation of synaptic plasticity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045471">
<property type="term" value="P:response to ethanol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR001828">
<property type="entry name" value="ANF_lig-bd_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR019594">
<property type="entry name" value="Glu/Gly-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR001508">
<property type="entry name" value="Iono_rcpt_met"/>
</dbReference>
<dbReference type="InterPro" id="IPR001320">
<property type="entry name" value="Iontro_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR018884">
<property type="entry name" value="NMDAR2_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR028082">
<property type="entry name" value="Peripla_BP_I"/>
</dbReference>
<dbReference type="Pfam" id="PF01094">
<property type="entry name" value="ANF_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00060">
<property type="entry name" value="Lig_chan"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF10613">
<property type="entry name" value="Lig_chan-Glu_bd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF10565">
<property type="entry name" value="NMDAR2_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00177">
<property type="entry name" value="NMDARECEPTOR"/>
</dbReference>
<dbReference type="SMART" id="SM00918">
<property type="entry name" value="Lig_chan-Glu_bd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00079">
<property type="entry name" value="PBPe"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF53822">
<property type="entry name" value="SSF53822"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0407">Ion channel</keyword>
<keyword id="KW-0406">Ion transport</keyword>
<keyword id="KW-1071">Ligand-gated ion channel</keyword>
<keyword id="KW-0458">Lysosome</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0628">Postsynaptic cell membrane</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0770">Synapse</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="signal peptide" evidence="8">
<location>
<begin position="1"/>
<end position="26"/>
</location>
</feature>
<feature type="chain" description="Glutamate receptor ionotropic, NMDA 2B" id="PRO_0000011577">
<location>
<begin position="27"/>
<end position="1484"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="6">
<location>
<begin position="27"/>
<end position="557"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="558"/>
<end position="576"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="6">
<location>
<begin position="577"/>
<end position="603"/>
</location>
</feature>
<feature type="intramembrane region" description="Discontinuously helical" evidence="6">
<location>
<begin position="604"/>
<end position="623"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="6">
<location>
<begin position="624"/>
<end position="630"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="631"/>
<end position="646"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="6">
<location>
<begin position="647"/>
<end position="817"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="818"/>
<end position="837"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="6">
<location>
<begin position="838"/>
<end position="1484"/>
</location>
</feature>
<feature type="region of interest" description="Pore-forming" evidence="5">
<location>
<begin position="604"/>
<end position="623"/>
</location>
</feature>
<feature type="region of interest" description="Glutamate binding" evidence="6">
<location>
<begin position="690"/>
<end position="691"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DAPK1" evidence="7">
<location>
<begin position="1292"/>
<end position="1304"/>
</location>
</feature>
<feature type="short sequence motif" description="PDZ-binding" evidence="4">
<location>
<begin position="1482"/>
<end position="1484"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-His">
<location>
<begin position="984"/>
<end position="989"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-His">
<location>
<begin position="1361"/>
<end position="1364"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="6">
<location>
<position position="127"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="6">
<location>
<position position="284"/>
</location>
</feature>
<feature type="binding site" description="Glutamate" evidence="6">
<location>
<position position="514"/>
</location>
</feature>
<feature type="binding site" description="Glutamate" evidence="6">
<location>
<position position="519"/>
</location>
</feature>
<feature type="binding site" description="Glutamate" evidence="6">
<location>
<position position="732"/>
</location>
</feature>
<feature type="site" description="Functional determinant of NMDA receptors" evidence="4">
<location>
<position position="615"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="882"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="886"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="917"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="920"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="7">
<location>
<position position="962"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="7">
<location>
<position position="1039"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="1058"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="1061"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="1064"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="7">
<location>
<position position="1109"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="7">
<location>
<position position="1133"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="1143"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="7">
<location>
<position position="1155"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="1255"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="1259"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DAPK1" evidence="7">
<location>
<position position="1303"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="7">
<location>
<position position="1474"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="74"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="341"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="348"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="444"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="491"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="542"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="688"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="86"/>
<end position="321"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="429"/>
<end position="456"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="436"/>
<end position="457"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="746"/>
<end position="801"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE27; unknown pathological significance; dbSNP:rs1057519553." id="VAR_078235" evidence="22">
<original>V</original>
<variation>M</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs201094029." id="VAR_079943" evidence="11">
<original>V</original>
<variation>I</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with schizophrenia; unknown pathological significance." id="VAR_079944" evidence="11">
<original>I</original>
<variation>N</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs138098032." id="VAR_079945" evidence="11">
<original>A</original>
<variation>V</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with schizophrenia; unknown pathological significance." id="VAR_079946" evidence="11">
<original>L</original>
<variation>M</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_011317" evidence="26">
<original>S</original>
<variation>N</variation>
<location>
<position position="407"/>
</location>
</feature>
<feature type="sequence variant" description="In MRD6; decreased protein abundance; decreased localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency; dbSNP:rs527236034." id="VAR_079947" evidence="15 21">
<original>E</original>
<variation>G</variation>
<location>
<position position="413"/>
</location>
</feature>
<feature type="sequence variant" description="In MRD6; decreased protein abundance; decreased localization to the cell membrane; dbSNP:rs1565478152." id="VAR_079948" evidence="21">
<original>C</original>
<variation>R</variation>
<location>
<position position="436"/>
</location>
</feature>
<feature type="sequence variant" description="In MRD6; decreased protein abundance; decreased localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by increased glutamate and glycine potency and increased open probability; dbSNP:rs397514555." id="VAR_076764" evidence="13 21">
<original>C</original>
<variation>Y</variation>
<location>
<position position="456"/>
</location>
</feature>
<feature type="sequence variant" description="In MRD6; decreased protein abundance; decreased localization to the cell membrane; decreased glutamate-gated calcium ion channel activity characterized by decreased glutamate potency and increased glycine potency." id="VAR_079949" evidence="21">
<original>C</original>
<variation>F</variation>
<location>
<position position="461"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE27; decreased protein abundance; decreased localization to the cell membrane; increased glutamate-gated calcium ion channel activity via an allosteric effect which is characterized by increased glutamate and glycine potency and increased open probability; the mutant channel is less sensitive to magnesium inhibition and has increased calcium permeability compared to wild-type; dbSNP:rs672601378." id="VAR_072663" evidence="14 21">
<original>R</original>
<variation>H</variation>
<location>
<position position="540"/>
</location>
</feature>
<feature type="sequence variant" description="In MRD6; no effect on localization to the cell membrane; loss of glutamate-gated calcium ion channel activity; dbSNP:rs397514556." id="VAR_069384" evidence="12 23">
<original>P</original>
<variation>L</variation>
<location>
<position position="553"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE27; severe phenotype with early onset seizures; gain of function mutation; results in neuronal hyperexcitability; the mutant channel is not inhibited by magnesium and has increased calcium permeability compared to wild-type; dbSNP:rs672601377." id="VAR_072664" evidence="14">
<original>N</original>
<variation>I</variation>
<location>
<position position="615"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE27; severe phenotype with early onset seizures; gain of function mutation; results in neuronal hyperexcitability; the mutant channel is not inhibited by magnesium and has increased calcium permeability compared to wild-type; dbSNP:rs672601376." id="VAR_072665" evidence="14">
<original>V</original>
<variation>G</variation>
<location>
<position position="618"/>
</location>
</feature>
<feature type="sequence variant" description="In MRD6; decreased protein abundance; no effect on localization to the cell membrane; no significant effect on calcium ion transmembrane import into cytosol; analysis of agonist dose-response curves for glutamate and glycine are not consistent; dbSNP:rs387906636." id="VAR_065900" evidence="10 21">
<original>R</original>
<variation>C</variation>
<location>
<position position="682"/>
</location>
</feature>
<feature type="sequence variant" description="In MRD6; decreased protein abundance; decreased localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by increased glutamate and glycine potency; dbSNP:rs1555103971." id="VAR_079950" evidence="21">
<original>R</original>
<variation>H</variation>
<location>
<position position="696"/>
</location>
</feature>
<feature type="sequence variant" description="In MRD6; dbSNP:rs797044849." id="VAR_078647" evidence="16">
<original>G</original>
<variation>E</variation>
<location>
<position position="820"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated variant found in a patient with autism spectrum disorder." id="VAR_079951" evidence="11">
<original>L</original>
<variation>V</variation>
<location>
<position position="825"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with schizophrenia; unknown pathological significance." id="VAR_079952" evidence="11">
<original>Q</original>
<variation>R</variation>
<location>
<position position="1014"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs201963596." id="VAR_079953" evidence="11">
<original>G</original>
<variation>S</variation>
<location>
<position position="1026"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_079954" evidence="11">
<original>M</original>
<variation>R</variation>
<location>
<position position="1342"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with autism spectrum disorder; unknown pathological significance; dbSNP:rs201463390." id="VAR_079955" evidence="11">
<original>S</original>
<variation>L</variation>
<location>
<position position="1415"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs748128078." id="VAR_079956" evidence="11">
<original>L</original>
<variation>F</variation>
<location>
<position position="1424"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with Landau-Kleffner syndrome; unknown pathological significance; dbSNP:rs758042475." id="VAR_078236" evidence="22">
<original>P</original>
<variation>A</variation>
<location>
<position position="1439"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with schizophrenia; unknown pathological significance; dbSNP:rs756790727." id="VAR_079957" evidence="11">
<original>S</original>
<variation>F</variation>
<location>
<position position="1452"/>
</location>
</feature>
<feature type="mutagenesis site" description="Changed glutamate-gated calcium ion channel activity characterized by increased glutamate and glycine potency and slowed response rise time and deactivation time course." evidence="23">
<original>P</original>
<variation>R</variation>
<location>
<position position="553"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased glutamate and glycine agonist potency." evidence="24">
<original>M</original>
<variation>V</variation>
<location>
<position position="818"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAD00659." ref="3" evidence="31">
<original>V</original>
<variation>A</variation>
<location>
<position position="434"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA69920." ref="5" evidence="31">
<original>G</original>
<variation>A</variation>
<location>
<position position="745"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA69920/AAA74930." ref="5" evidence="31">
<original>K</original>
<variation>N</variation>
<location>
<position position="773"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA69920/AAA74930." ref="5" evidence="31">
<original>W</original>
<variation>C</variation>
<location>
<position position="796"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA69920/AAA74930." ref="5" evidence="31">
<original>T</original>
<variation>P</variation>
<location>
<position position="888"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA69920/AAA74930." ref="5" evidence="31">
<original>L</original>
<variation>V</variation>
<location>
<position position="902"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB60368." ref="1" evidence="31">
<original>SA</original>
<variation>RP</variation>
<location>
<begin position="920"/>
<end position="921"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA69920/AAA74930." ref="5" evidence="31">
<original>L</original>
<variation>S</variation>
<location>
<position position="958"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA69920." ref="5" evidence="31">
<original>VYQ</original>
<variation>DHY</variation>
<location>
<begin position="980"/>
<end position="982"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA69920." ref="5" evidence="31">
<original>I</original>
<variation>M</variation>
<location>
<position position="1056"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB49993." ref="2" evidence="31">
<original>V</original>
<variation>I</variation>
<location>
<position position="1167"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="34"/>
<end position="44"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="47"/>
<end position="50"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="62"/>
<end position="73"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="78"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="94"/>
<end position="100"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="107"/>
<end position="119"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="123"/>
<end position="127"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="128"/>
<end position="131"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="143"/>
<end position="147"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="150"/>
<end position="164"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="168"/>
<end position="173"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="179"/>
<end position="191"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="193"/>
<end position="195"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="198"/>
<end position="204"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="215"/>
<end position="221"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="226"/>
<end position="232"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="234"/>
<end position="246"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="255"/>
<end position="258"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="260"/>
<end position="263"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="278"/>
<end position="282"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="284"/>
<end position="286"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="289"/>
<end position="311"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="321"/>
<end position="323"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="324"/>
<end position="327"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="328"/>
<end position="330"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="336"/>
<end position="339"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="355"/>
<end position="359"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="362"/>
<end position="367"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="373"/>
<end position="379"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="384"/>
<end position="387"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5EWJ"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5EWL"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5EWM"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="A7XY94"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q00960"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q01097"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255"/>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10748157"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20890276"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22833210"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23033978"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23160955"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24272827"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24863970"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25356899"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26875626"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26912815"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26919761"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27458189"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27839871"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27864847"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28095420"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28126851"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28130356"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7999784"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8768735"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9547169"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7959773"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7999784"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000305"/>
<sequence length="1484" mass="166367" checksum="40AEB12BE6E50CEF" modified="2001-06-20" version="3" precursor="true">MKPRAECCSPKFWLVLAVLAVSGSRARSQKSPPSIGIAVILVGTSDEVAIKDAHEKDDFHHLSVVPRVELVAMNETDPKSIITRICDLMSDRKIQGVVFADDTDQEAIAQILDFISAQTLTPILGIHGGSSMIMADKDESSMFFQFGPSIEQQASVMLNIMEEYDWYIFSIVTTYFPGYQDFVNKIRSTIENSFVGWELEEVLLLDMSLDDGDSKIQNQLKKLQSPIILLYCTKEEATYIFEVANSVGLTGYGYTWIVPSLVAGDTDTVPAEFPTGLISVSYDEWDYGLPARVRDGIAIITTAASDMLSEHSFIPEPKSSCYNTHEKRIYQSNMLNRYLINVTFEGRNLSFSEDGYQMHPKLVIILLNKERKWERVGKWKDKSLQMKYYVWPRMCPETEEQEDDHLSIVTLEEAPFVIVESVDPLSGTCMRNTVPCQKRIVTENKTDEEPGYIKKCCKGFCIDILKKISKSVKFTYDLYLVTNGKHGKKINGTWNGMIGEVVMKRAYMAVGSLTINEERSEVVDFSVPFIETGISVMVSRSNGTVSPSAFLEPFSADVWVMMFVMLLIVSAVAVFVFEYFSPVGYNRCLADGREPGGPSFTIGKAIWLLWGLVFNNSVPVQNPKGTTSKIMVSVWAFFAVIFLASYTANLAAFMIQEEYVDQVSGLSDKKFQRPNDFSPPFRFGTVPNGSTERNIRNNYAEMHAYMGKFNQRGVDDALLSLKTGKLDAFIYDAAVLNYMAGRDEGCKLVTIGSGKVFASTGYGIAIQKDSGWKRQVDLAILQLFGDGEMEELEALWLTGICHNEKNEVMSSQLDIDNMAGVFYMLGAAMALSLITFICEHLFYWQFRHCFMGVCSGKPGMVFSISRGIYSCIHGVAIEERQSVMNSPTATMNNTHSNILRLLRTAKNMANLSGVNGSPQSALDFIRRESSVYDISEHRRSFTHSDCKSYNNPPCEENLFSDYISEVERTFGNLQLKDSNVYQDHYHHHHRPHSIGSASSIDGLYDCDNPPFTTQSRSISKKPLDIGLPSSKHSQLSDLYGKFSFKSDRYSGHDDLIRSDVSDISTHTVTYGNIEGNAAKRRKQQYKDSLKKRPASAKSRREFDEIELAYRRRPPRSPDHKRYFRDKEGLRDFYLDQFRTKENSPHWEHVDLTDIYKERSDDFKRDSVSGGGPCTNRSHIKHGTGDKHGVVSGVPAPWEKNLTNVEWEDRSGGNFCRSCPSKLHNYSTTVTGQNSGRQACIRCEACKKAGNLYDISEDNSLQELDQPAAPVAVTSNASTTKYPQSPTNSKAQKKNRNKLRRQHSYDTFVDLQKEEAALAPRSVSLKDKGRFMDGSPYAHMFEMSAGESTFANNKSSVPTAGHHHHNNPGGGYMLSKSLYPDRVTQNPFIPTFGDDQCLLHGSKSYFFRQPTVAGASKARPDFRALVTNKPVVSALHGAVPARFQKDICIGNQSNPCVPNNKNPRAFNGSSNGHVYEKLSSIESDV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

